Success Metrics

Active Trials
3(60%)

Phase Distribution

Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Other(2)

Detailed Status

Recruiting2
unknown2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting240%
active_not_recruiting120%
unknown240%

Recent Activity

3 active trials
Showing 5 of 5
recruiting

Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance

NCT06658730
active_not_recruiting

The Helsinki Unruptured Intracranial Aneurysm Quality of Care Study

NCT06147102
recruitingnot_applicable

Patient Selection Using MR With Non-Perfusion Imaging for Endovascular Treatment Within 6 to 24 Hours

NCT05735301
unknown

Carotid Web and Stroke Registry.

NCT05475080
unknown

Perfusion Computer Tomography: Imaging and Clinical Validation Following Reperfusion Therapy in Acute Ischaemic Stroke

NCT02309970

Clinical Trials (5)

Showing 5 of 5 trials
NCT06658730

Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance

Recruiting
NCT06147102

The Helsinki Unruptured Intracranial Aneurysm Quality of Care Study

Active Not Recruiting
NCT05735301Not Applicable

Patient Selection Using MR With Non-Perfusion Imaging for Endovascular Treatment Within 6 to 24 Hours

Recruiting
NCT05475080

Carotid Web and Stroke Registry.

Unknown
NCT02309970

Perfusion Computer Tomography: Imaging and Clinical Validation Following Reperfusion Therapy in Acute Ischaemic Stroke

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5